FRED-X
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
-
Clinical Trial Information
Trial Contact: Carlo, Charlene S; Monserrate, Francheska; Melendez, Thomas L; Flores-Vega, Mariangelis
Trial Phone: 321.841.1324 ; 321-841-4717 ; 321.841.6813 ; 321-841-717
-
IRB No: W22.124.06
Protocol Abbrev: FRED-X
Principal Investigator: Jay Ashok Vachhani, MD
Phase: Device: Category N/A
Age Group: Adult
Secondary Protocol No: CL11023
Treatment: The FRED™ X™ System
Therapies Involved: Surgery
ClinicalTrials.gov ID: NCT05409989
-
Objective
The objective of this study is to generate contemporaneous clinical data to facilitate a reasonable comparison of the performance of the FRED™ X™ device with the performance of the FRED™ device.
-
Key Eligibility
Subject has single target aneurysm in the internal carotid artery from petrous segment to the terminus of the internal carotid artery.
